ConductScience.org, home

Paper · 7531365

Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases.

Uckun FM and 8 others. Science, 1995. Cited by 239 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Papers, record 7531365. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7531365

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases.
PubMed
Journal
Science
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
239
iCite
Relative citation ratio, by iCite
6.08
iCite
Revised in PubMed
2019-06-18
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uckun FMF M
2Evans WEW E
3Forsyth CJC J
4Waddick KGK G
5Ahlgren LTL T
6Chelstrom LML M
7Burkhardt AA
8Bolen JJ
9Myers DED E

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Antigens, Differentiation, B-LymphocyteMajor topic
ImmunoconjugatesMajor topic
IsoflavonesMajor topic
Precursor B-Cell Lymphoblastic Leukemia-LymphomaMajor topic
Protein-Tyrosine KinasesMajor topic
Animals
Antibodies, Monoclonal
Antigens, CD19
Apoptosis
DNA Damage
DNA, Neoplasm
Genistein
Leukemic Infiltration
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Mice
Mice, SCID
Tissue Distribution
Tumor Cells, Cultured

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-42111NCI NIH HHSUnited StatesR01CA042111PubMed and NIHNIH RePORTER
CA-42633NCI NIH HHSUnited StatesR01CA042633PubMed and NIHNIH RePORTER
CA-51425NCI NIH HHSUnited StatesR01CA051425PubMed and NIHNIH RePORTER
R29CA042111NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 239 citations.

PMIDTitleJournalYearIn PapersSource
37,838,981Molecular pharmacology of the onco-TRP channel TRPV6.Channels (Austin)2023https://conductscience.org/library/papers/37838981PubMed
37,457,582The influence of COVID-19 on colorectal cancer was investigated using bioinformatics and systems biology techniques.Front Med (Lausanne)2023https://conductscience.org/library/papers/37457582PubMed
37,160,865Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein.Nat Commun2023https://conductscience.org/library/papers/37160865PubMed
36,936,272The role of isoflavones in augmenting the effects of radiotherapy.Front Oncol2022https://conductscience.org/library/papers/36936272PubMed
36,091,808Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis.Front Pharmacol2022https://conductscience.org/library/papers/36091808PubMed
35,815,271Genistein: Therapeutic and Preventive Effects, Mechanisms, and Clinical Application in Digestive Tract Tumor.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35815271PubMed
32,332,902Phytochemical analysis and biological activities of in vitro cultured Nidularium procerum, a bromeliad vulnerable to extinction.Sci Rep2020https://conductscience.org/library/papers/32332902PubMed
30,292,138Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.Mol Ther Nucleic Acids2018https://conductscience.org/library/papers/30292138PubMed
25,892,662Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.Semin Cancer Biol2015https://conductscience.org/library/papers/25892662PubMed
24,910,947CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.Integr Biol (Camb)2014https://conductscience.org/library/papers/24910947PubMed

1 to 10 of 34

See all 34 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
TXK7,294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7531365

GET https://conductscience.org/api/papers/v1/7531365/cited_by?page=2